Skip to main content

Postdoc Portrait: Ananya Naha Probes Ocular Cells in Glaucoma Research

This postdoctoral researcher investigates how ocular cells respond to mechanical stress to discover new therapies for glaucoma.

Brought to you byThe Scientist
| 2 min read
Headshot of postdoctoral researcher Ananya Naha.
Register for free to listen to this article
Listen with Speechify
0:00
2:00

Ananya Naha is a postdoctoral researcher at the University of South Florida. There, she studies ocular mechanobiology and tissue remodeling to uncover novel therapeutic strategies for glaucoma. In this Postdoc Portrait interview, she emphasizes the importance of her research.

Translating Biomechanics to Ocular Tissue Remodeling

Q | What drew you to studying glaucoma?

Previously I worked in the orthopedics field, and this postdoctoral position led me to study the eye. Glaucoma research offers an opportunity to translate insights from biomechanics into a deeper understanding of disease mechanisms and potentially into new therapeutic strategies that preserve vision.

Q | What’s one thing you learned from your research that you didn’t expect?

I am still learning and hoping that a dynamic conversation between mechanical forces and biology in the eye tissues would reinforce the idea that disease progression is often not driven solely by mechanical stress itself, but by how cells interpret and respond to that stress. Understanding this interplay has been one of the most interesting and unexpected lessons from my research experience.

Transforming Glaucoma Therapeutics and Vision Protection

Q | If your research succeeds, what could it change for science or society?

From a societal perspective, the impact could be substantial because glaucoma is a leading cause of irreversible blindness worldwide. Current treatments primarily focus on reducing eye pressure, but many patients continue to lose vision despite treatment. If our research reveals new ways to protect ocular tissues or modify harmful cellular responses to mechanical stress, it could lead to more effective therapies that preserve vision and improve quality of life for millions of people.

Q | What question are you most excited to answer next?

I would like to investigate whether we can develop potential treatments to target specific pathways to reduce the intraocular pressure in glaucoma.

Responses have been edited for length and clarity.

Are you a researcher who would like to be featured in the “Postdoc Portraits” series? Send in your application here.

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo